Navigation Links
InterMune Reports First Quarter 2009 Financial Results and Business Highlights
Date:4/30/2009

ween pirfenidone and placebo in the percentage of patients that experienced a serious adverse event (SAE) and the pattern of adverse events (AEs) was, in general, comparable to that observed in previous clinical studies of pirfenidone.
  • InterMune is preparing an NDA for submission to the FDA in the summer of 2009, to be followed by an MAA submission to the European Medicines Agency (EMEA) around the end of 2009.
  • Results from the CAPACITY studies will be presented in an oral late-breaker session at 3:35 p.m. PDT on May 19 at the International Conference of the American Thoracic Society (ATS) in San Diego.

  • ITMN-191:

    • On January 12, InterMune announced top-line results from a 14-day, Phase 1b study of ITMN-191 in combination with Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin).
      • After 14 days of triple combination therapy, the median change in HCV RNA from baseline exceeded 5 log10 in five of the six dosage cohorts, and was -5.4 log10 and -5.7 log10 in the best performing q12h and q8h cohorts, respectively. ITMN-191 delivered viral kinetic performance that is comparable to the best results reported to date for other protease inhibitors in similar experiments.
      • There was no evidence of viral rebound during ITMN-191 treatment in any cohort.
      • On April 24, InterMune reported that data from the triple combination study had informed the dose selection for the Phase 2b program of ITMN-191. The Phase 2b trial, expected to begin in the summer of 2009, will study both q12h regimens (600mg and 900mg q12h) and a q8h regimen (300mg q8h) and both 12-week and 24-week treatment durations.

    • At the Annual Meeting of the European Association for the Study of the Liver (EASL
      '/>"/>

    SOURCE InterMune, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. InterMune to Release First Quarter Financial Results on April 30
    2. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
    3. InterMune to Present at Canaccord Adams Hepatitis C Conference
    4. InterMune to Present at Citis 4th Annual Biotech Day
    5. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
    6. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
    7. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
    8. InterMune Announces Issuance of U.S. Patent for ITMN-191
    9. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
    10. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
    11. InterMune to Present at J.P. Morgan Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/1/2014)... 1, 2014 Industry leaders ... to engage around the theme, ,Commercial Opportunities in the ...   Elsevier , a world-leading provider ... will host a gathering of some of the industry,s ... impacting healthcare today and in the future. The ...
    (Date:9/30/2014)... Pacific Northwest Biotechnology, LLC - Product ... Markets Direct,s, ,Pacific Northwest Biotechnology, LLC - Product ... the Pacific Northwest Biotechnology, LLC,s pharmaceutical research and ... on the current therapeutic developmental pipeline of Pacific ... various stages, therapeutics assessment by drug target, mechanism ...
    (Date:9/30/2014)... Proove Biosciences , the commercial and research leader ... genetic test built upon research from their published P.A.I.N. ... provide physicians with an objective way to understand theirs ... between individuals. With this new test, physicians will be ... predisposition that will affect their pain tolerance. , The ...
    (Date:9/30/2014)... Genedata, a leading provider ... and related life science research, today announced ... Selector as its host-pathogen data analysis platform ... a European consortium dedicated to improving the ... anti-fungal drug therapies. Genedata Selector supports this ...
    Breaking Biology Technology:Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3
    ... INDIANAPOLIS, Oct. 20, 2011 BioStorage Technologies, Inc. ... biomaterial storage and cold chain logistics for the ... Benchmarking Symposium at the International Contract Services Expo ... Germany. The symposium will include ...
    ... 2011 MiMedx Group, Inc.  (OTCBB: MDXG), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... "Pete" Petit, has been inducted into the National Academy ... Academy of Engineering is among the highest professional distinctions ...
    ... Oct. 20, 2011 Med track is pleased ... 2011. Attendees of the show will be the first ... the newly designed platform. With deeply integrated datasets and ... professionals in business development, competitive intelligence and sales and ...
    Cached Biology Technology:BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo 2MiMedx Group's Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering 2Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011 2
    (Date:10/1/2014)... in the deserts, rainforests, prairies and forests of the ... City,s Central Park, according to a surprising new study ... Colorado Boulder. , The research team analyzed 596 ... and discovered a stunning diversity of below-ground life, most ... Only 8.5 percent to 16.2 percent of the organisms ...
    (Date:9/30/2014)... Ill. --- Do we think of nature as something that ... we need to "preserve?" Or do we think of ourselves ... part of nature, but what about a house? , ... are also reflected in our actions, our speech and in ... with the University of Washington, the American Indian Center of ...
    (Date:9/30/2014)... National Institutes of Health (NIH) awarded Lawrence Livermore ... an electrode array system that will enable researchers ... unprecedented resolution and scale. , LLNL,s grant-funded project ... Obama,s BRAIN (Brain Research through Advancing Innovative ... revolutionize our understanding of the human mind and ...
    Breaking Biology News(10 mins):Microbes in Central Park soil: If they can make it there, they can make it anywhere 2Microbes in Central Park soil: If they can make it there, they can make it anywhere 3The cultural side of science communication 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3
    ... Dua, an assistant professor of computer science, and ... engineering, are using their skills and technical knowledge ... of Defense with sensor networks and tracking capabilities. ... Tracking, or ATR, involves the development of fast ...
    ... are multifactorial: they are not simply the result of ... that can no longer carry out its job. Diabetes ... and environmental factors. Similarly, in biotechnology, processes cannot be ... process. It is the networks of interaction that Systems ...
    ... a leading publisher of scientific, technical and medical ... than 4,000 eBooks on ScienceDirect. eBooks on ScienceDirect ... the present. These include scientific and technical books ... from renowned imprints including Pergamon and Academic Press. ...
    Cached Biology News:Louisiana Tech researchers investigate tracking, sensors to assist Air Force 2Louisiana Tech researchers investigate tracking, sensors to assist Air Force 3Europe needs collective effort on System Biology, says ESF Task Force 2Europe needs collective effort on System Biology, says ESF Task Force 3Europe needs collective effort on System Biology, says ESF Task Force 44,000 e-Books now available on ScienceDirect 2
    ...
    ... and flexibility of the BDTM LSR, the first UV ... The BD LSR II has performance, capabilities, and ... Free up your high-performance cell sorter by moving your ... LSR II. The BD LSR II can be configured ...
    ... Flow Cytometer System is a full featured, two ... the C6 Flow Cytometer, CFlow Software, and a ... Cytometer System provides all the capabilities of the ... the price. The C6 Flow Cytometer System has ...
    ...
    Biology Products: